Dr Hannah Bridgewater
Supervisor Details
Research Interests
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus associated with the development of both lymphoid and epithelial tumours; and most recently, implicated in the development of autoimmune diseases such as MS, ME and long COVID. A key challenge in the study of EBV in epithelial cells is that in vitro models are not well developed, with the more advanced models being developed in B cells. This is due to the difficulty in establishing infection in epithelial cells in cell culture. Working alongside Prof. Lawrence Young in the Medical school, my group is working to overcome this. We are interested in understanding latent vs lytic EBV infection and in therapeutically targeting epithelial based EBV positive tumours.
With my early research years focusing on metallodrug, my group will also continue to collaborate on projects studying these therapeutic avenues as well, in a variety of cancer types.
Other research interests lie around the resolution of inflammation and impaired immunity. This work extends from a post-doctoral position I held with Prof. Derek Gilory at UCL, and we continue to work in collaboration.
Scientific Inspiration
CAROL GREIDER: female Nobel laureate paving the way for women in STEM.
MIBTP Project Details
Current Projects (2025-26)
Primary supervisor for: